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ABSTRACT
Xeroderma pigmentosum (XP) type C is a rare autosomal recessive disorder that occurs 
because of inactivation of the xeroderma pigmentosum group C (XPC) protein, which is 
an important DNA damage recognition protein involved in DNA nucleotide excision 
repair (NER). This defect, which prevents removal of a wide array of direct and indirect 
DNA lesions, is associated with a decrease in catalase activity. As a novel photoprotective 
approach, lentivirus-mediated catalase overexpression in XPC human keratinocytes results 
in a marked decrease in sunburn cell formation, caspase-3 activation, and p53 accu-
mulation following UVB irradiation. While not correcting the gene defect, indirect 
gene therapy using antioxidant enzymes may be helpful in limiting photosensitivity in 
XP type C, as well as in other monogenic/polygenic photosensitive disorders character-
ized by reactive oxygen species (ROS) accumulation. Hypoxia-inducible factor-1 (HIF-1), 
a major transcription factor sensitive to oxygen levels, responds to various stress factors. 
As a common stressor of skin, UVB induces a biphasic HIF-1α variation through ROS 
generation in keratinocytes. HIF-1α has an important regulator effect on the expression 
of XPC protein and other NER genes, indicating indirect regulation of NER by ROS. The 
intrinsic genomic instability arising in XP type C provides a good opportunity to investigate 
the complex molecular mechanisms underlying the Warburg effect (the shift of mito-
chondrial metabolism towards glycolysis). Overall, the monogenic disorder XP type C 
is a powerful tool for studying photoprotection and cancer.
Copyright © 2010, Taiwanese Dermatological Association. 
Published by Elsevier Taiwan LLC. All rights reserved.
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Introduction
Different causes of monogenic disease, such as albinisms and 
nucleotide excision repair (NER) diseases, contribute to pho-
tosensitivity and cancer. The most important contributors to 
UV adaptive responses include (1) DNA lesions, which can 
induce a pigmentary response1 and DNA repair machinary; 
(2) apoptosis, which deletes damaged cells; (3) enzymatic 
and non enzymatic antioxidant defenses; (4) melanogenesis; 
(5) stratum corneum, which acts as a physical barrier and a 
sensor for UV danger responses;2 and (6) the skin immune 
system, both innate and adaptive.3 Interestingly, most of these 
responses include reactive oxygen species (ROS) mediated 
effects. Two major effects of ROS have been identified, 
namely oxidative lesions on large molecules (complex gluc-
ids, lipids, proteins and nucleic acids), and physiologic sign-
aling as second messengers to modulate transcription factors 
such as upstream stimulatory factor, activator protein-1, and 
hypoxia-inducible factor-1α (HIF-1α).4–8
From clinical observations to antioxidant 
photoprotective therapy
Heterogeneity for skin cancer proneness in two DNA 
repair disorders, trichothiodystrophy and xeroderma 
pigmentosum
UV irradiation causes two major photoproducts in DNA: 
cyclobutane pyrimidine dimers (CPDs) and (6-4) pyrimidine-
pyrimidone photoproducts (6-4PPs). Measure ment of 
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post-UV unscheduled DNA synthesis (UDS) testing indicates 
that similar impairment of DNA repair could lead to disorders 
with different phenotypes and different proneness to skin 
cancer. In fact, the main system responsible for correcting 
UV-induced damage is the NER, which includes two distinct 
subpathways: global genome repair (GGR), which repairs 
DNA damage throughout the genome; and transcription-
coupled repair (TCR), which repairs DNA lesions in the 
transcribed strand of active genes (Figure 1). Absence or 
dysfunction of NER results in three distinct disorders: xero-
derma pigmentosum (XP), trichothio dystrophy (TTD), and 
Cockayne syndrome. Among them, XP and TTD are associ-
ated with reduced UDS levels.9,10
XP is an autosomal recessive NER disease with catalase 
de ficiency and cancer11 which manifests with delayed clini -
cal photosensitivity and a highly increased predisposition 
Figure 1 Molecular mechanisms of global genome repair (GGR) and transcription-coupled repair (TCR). Nucleotide excision repair (NER) is a 
highly versatile system capable of removing a wide variety of helix-distorting lesions from genomic DNA. This system proceeds through two dis-
tinct yet overlapping pathways, GGR and TCR, where the main difference is in the recognition step. In GGR, DNA damage throughout the genome 
is recognized by xeroderma pigmentosum type C (XPC) and type E (XPE) proteins (or UV-DDB), while in TCR, damage that blocks transcription is 
detected by the chondroitin sulfate A and B proteins. In the unwinding step, transcription factor II H (including XPB, XPD, p8/TTDA and several 
other subunits), most likely together with XP type G (XPG), type A (XPA) proteins and replication protein A, unwinds the DNA helix through its 
DNA helicase activity. After incisions have been made on both sides of the lesion by XPF-ERCC1 and XPG, the oligonucleotide containing the 
damaged base(s) is released as part of a piece of 25–30 bases. Finally, the gapped DNA region is restored by a DNA polymerase (δ or ε) and DNA 
ligase. The synthesis of this repaired DNA requires proliferating cell nuclear antigen, which forms a homotrimeric clamp on template strands, and 
replication factor C, which is a heteropentameric, DNA-dependent ATPase complex.
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to UV-induced skin cancers. The phenotype includes xerosis 
and hyperpigmentation. Extra cutaneous specific lesions may 
involve the eye and central nervous system. Internal can-
cers can also occur, especially leukemia and various solid 
cancers. This phenotype is genetically heterogeneous (8 
genes, XP-A to XP-G and the variant XP-V). Apart from xero-
derma pigmentosum group C (XPC) protein, which serves 
to recognize the damaged bases at the beginning of GGR, 
other factors participate in both GGR and TCR. The variant 
form is milder and the age of onset of cancers is 40 years 
old. This disorder corresponds to a different pathomechanism 
targeting the bypassing of CPDs due to a defect in DNA 
polymerase η.9,10
Cockayne syndrome is a rare autosomal recessive disease 
with features of photosensetivity, retinal pigmentation, and 
progressive neurological degeneration. This disease is caused 
by a defect in chondroitin sulfate A or B proteins, which are 
important in the recognition of damaged bases at the be-
ginning of TCR. Unlike XP, Cockayne syndrome has normal 
levels of UDS and is not associated with skin cancer.10
The so called “photosensitive” TTD corresponds by UDS 
testing to an XP-type NER deficiency in vitro without cata-
lase activity deficiency11 or cancer,12 but is associated with 
premature aging. The early phenotype is dominated by 
abnormal terminal differentiation of the epidermis and 
hairs, which causes ichthyosis (collodion baby is common) 
and hair brittleness. The molecular basis of TTD with NER 
deficiency has been partially identified and corresponds to 
mutations of subunits (XPB, XPD, and p8/TFB5 also called 
TTDA, with XPD mutants being the most common) of tran-
scription factor II H (TFIIH) that acts downstream of XPC in 
the GGR chain.13 Interestingly, the TTD ichthyotic pheno-
type is strongly associated with in vitro photosensitivity, 
suggesting a link of TFIIH with the regulation of epidermal 
and hair terminal differentiation. Figure 211 shows the re-
spective clinical features of XP and TTD.
Recently, Chiganças et al14 examined why TTD/XPD 
(TTD patients with a mutated XPD gene) patients are more 
severely affected in the NER of CPDs than of 6-4PPs. They 
showed that some TTD/XPD mutations affect the recruit-
ment of TFIIH specifically to CPDs, but not to 6-4PPs. For 
6-4PPs, they found that TFIIH complexes carrying an NH2-
terminal XPD mutated protein are also deficient in recruit-
ment of NER proteins downstream of TFIIH. Chiganças et al14 
also demonstrated that a defect in the NER of CPDs in some 
TTD/XPD patients can be partially associated with the ac-
cessibility of DNA damage in closed chromatin regions.14 
Nishiwaki et al15 showed that when comparing XPD mutants 
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Figure 2 Clinical phenotype of xeroderma pigmentosum (XP) type C, and trichothiodystrophy (TTD). (A) XP type C is characterized by a marked 
photosensitivity, skin freckling typical of photoaging, and early development of skin cancer. (B) Photosensitive TTD is characterized by ichthyosis, 
an early marker in the case of collodion baby syndrome, and hair brittleness; patient at birth (collodion baby). (C) The same patient featured in (B) 
at age 4. Com pared with the skin aging of an XP type C patient at age 3 shown in (A). The TTD patient depicted here is XP type B and has mini-
mally associated involvement but limited DNA repair proficiency in vitro (see reference 11 for details). (D) Typical TTD tiger tail pattern of hairs 
under a polarizing microscope.
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that the second (but not the first) increase in ROS produc-
tion has a major role in UVB-induced apoptosis. We found 
that catalase overexpression inhibits only the late increase 
in ROS levels and that this inhibition decreases apoptosis 
with a reduction of caspase-9 activation accompanied by a 
decrease in p53. Irradiation at a low temperature (Figure 3) 
also reduces UV-induced apoptosis in normal keratinocytes 
independently of any changes in p53, with a decrease in 
caspase-8 activation. Maintaining cells at a low tempera-
ture and catalase overexpression has additive effects on ap-
optosis reduction, indicating that catalase overexpression 
mainly reduces the activation of the intrinsic pathway. Our 
data further suggested that catalase (but not CuZnSOD) over-
expression has a protective role against UVB irradiation by 
preventing DNA damage mediated by a late ROS increase, 
supporting the therapeutic concept of the possible rein-
forcement of natural antioxidant photoprotective defenses 
against sunburn and possibly skin cancer.26
Stable genetic modification of human skin equivalents 
to examine the concept of antioxidant gene therapy 
and application to XP
To confirm our observations in vitro in a more physiological 
system, we investigated the effects of UVA and UVB irradi-
ation on reconstructed epidermis made with human kerati-
nocytes transduced by CuZnSOD, MnSOD or catalase. We 
found that following UVB irradiation, there is a marked de-
crease in apoptotic keratinocytes (also know as sunburn 
cells), caspase-3 activation and p53 accumulation in human 
reconstructed epidermis overexpressing catalase. Moreover, 
UVA-induced hypertrophy and DNA oxidation (8-oxode-
oxyguanosine) are decreased by catalase overexpression. 
giving rise to either XP or TTD phenotypes, TTD cell strains 
had an approximately 50% decrease in cellular TFIIH con-
tent and defective recruitment of TFIIH to DNA damage 
sites. These studies indicate that molecular mechanisms are 
related to differences in DNA repair capacity in TTD/XPD 
versus XP/XPD, but fail to explain the lack of increased in-
cidence of skin cancers in TTD patients. The decrease in 
catalase activity and its cofactor NADPH observed in XP 
cells versus TTD cells,16 which can affect cellular redox sta-
tus, may prove to be important for defining new therapeutic 
strategies.
Catalase as a physiological enhancer of 
photoprotection in keratinocytes of black individuals
In vitro studies have suggested that modulation of the epi-
dermal redox status is a good target for improving natural 
photoprotection. In vitro pigmented reconstructed epidermis, 
which was developed in our laboratory in the 1990s, is a 
good tool for assessing the various components of photo-
protection. We demonstrated that phototype affects not only 
constitutive and reactive melanogenesis, but also antioxidant 
cell status. In particular, catalase activity was found to be 
higher in keratinocytes of black individuals.17 Furthermore, 
recent evidence suggests that melanosomes could be a phys-
ical link for catalase transfer to keratinocytes.18
Catalase overexpression limits UVB-induced apoptosis 
in normal human keratinocytes
UV radiation is a well-known generator of ROS in different 
types of cells. To neutralize ROS, living cells have acquired 
several lines of defense systems including non-enzymatic 
(α–tocopherol and vitamin C) and enzymatic antioxidants 
at the forefront. When these systems are overwhelmed, de-
gradation systems such as proteasomes and autophagy in-
tervene. Finally, cell death (apoptosis) may occur. Apoptosis 
is a highly complex process involving extrinsic and intrin-
sic pathways through which caspase activation is triggered 
(Figure 3).19−21 Recent data have shown that in addition to 
death receptor activation and DNA damage, UVB-induced 
ROS generation contributes to induction of apoptosis.22 Re-
duction of the deleterious effects of UV-induced ROS through 
an increase in antioxidant defense systems supports this 
notion.23−25 However, it is unclear how ROS generation is 
interrelated to other apoptotic events (Figure 3).
Using UVB irradiation of normal human keratinocytes 
sustainably overexpressing catalase, MnSOD, and/or Cu-
ZnSOD, we investigated the role of UVB-induced ROS 
production and antioxidant enzymes in cell death and its 
relationships with other apoptotic pathways.26 While inves-
tigating the kinetics of ROS generation following UVB irra-
diation, we first showed that UVB irradiation induces an 
increase in ROS levels at two different time intervals, and 
Figure 3 UV-induced apoptosis in the epidermis. UVB-induced death 
receptor activation, DNA damage, and reactive oxygen species (ROS) 
generation all contribute to induction of apoptosis. Overexpression of 
antioxidant enzymes, especially catalase, limits apoptosis mainly 
through the reduction of a UV-induced intrinsic apoptotic pathway.
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These effects were not achieved by overexpression of 
CuZnSOD or MnSOD.27 To test the hypothesis that reinforce-
ment of antioxidant enzymes affects the phenotypic expres-
sion of severe photosensitive disorders, we extended our 
studies to epidermis reconstructed with XPC keratino cytes, 
based on previous findings of reduced catalase activity.11 
We found that catalase overexpression can reduce UVB-
induced apoptosis in epidermis reconstructed with XPC ke-
ratinocytes, and that reduced apoptosis is accompanied by 
a decrease in p53 accumulation.28 Direct gene therapy for 
XPC has been successfully attempted in vitro, and has shown 
complete correction of repair-defective cellular pheno-
types.29–32 However, in vivo attempts will probably be prob-
lematic because of the complete absence of the protein in 
affected patients, which means that an immune reaction is 
likely to occur in case of synthesis recovery. While not cor-
recting the gene defect, our study28 indicates that indirect 
gene therapy using antioxidant enzymes may be helpful in 
limiting photosensitivity in XPC. Furthermore, this novel 
type of therapy is theoretically applicable to other disorders 
of photoprotection, downstream of a primary gene defect, 
that are characterized by the accumulation of ROS.
ROS as second messengers: HIF-1a as a major 
regulator of UV responses including NER
HIF-1α has exquisite sensitivity to oxygen levels in the 
cellular environment and participates in the regulation of 
numerous genes involved in angiogenesis, glycolysis, apop-
tosis, migration and metastasis.33–36 HIF-1 is a heterodimeric 
factor consisting of two α and β subunits.37 In normoxia, 
HIF-1α is rapidly targeted for ubiquitination and proteaso-
mal degradation. The hydroxylation of HIF-1α mediated 
by prolyl-hydroxylases is a prerequisite for this degrada-
tion.33,38,39 Reduction in prolyl-hydroxylase activity under 
hypoxic conditions results in the stabilization and the ac-
cumulation of HIF-1α. Hypoxia-mediated ROS modulation 
and posttranscriptional modification (mainly phosphoryla-
tion) of HIF-1α is important in its stabilization and/or tran-
scriptional activation process.40,41
We decided to investigate HIF-1α expression and its re-
lationship with ROS production in keratinocytes in response 
to UVB irradiation, because ROS are known to influence 
HIF-1α regulation and hypoxia-induced apoptosis.42 More-
over, both the involvement of HIF in the modulation of cell 
responses to growth factors under normoxia in a ROS-
dependent manner42,43 and the UVB-mediated induction of 
vascular endothelial growth factor (one of the major HIF-1α 
target genes),44–46 lends further support to our hypothesis.
We demonstrated, for the first time, the mechanisms 
contributing to the modulation of HIF-1α in response to 
UVB-induced ROS production and the effect of HIF-1α 
on UVB-induced apoptosis. We found that UVB induces a 
biphasic HIF-1α variation through ROS generation with a rapid 
down-regulation of HIF-1α followed by a gradual increase. 
Our data revealed the following: (1) that the early increase 
in ROS levels is mostly dependent on the activity of a cyto-
plasmic NADPH oxidase, while the late increase in ROS 
levels originates from the mitochondria, and (2) that HIF-1α 
down-regulation immediately after irradiation is dependent 
on ROS produced by NADPH oxidase, whereas its late in-
crease in a phosphorylated form is induced by ROS pro-
duced in mitochondria through c-Jun N-terminal kinase and 
p38 mitogen-activated protein kinase activation (Figure 4).
Our results indicate that HIF-1α exerts a proapoptotic 
effect through both the extrinsic (caspase-8 activation) and 
the intrinsic (caspase-9 activation) apoptotic pathways. Fur-
thermore, we found that p53 activation following UV irra-
diation was affected by HIF-1α expression levels, suggesting 
a functional link between UVB-induced ROS production, 
HIF-1α variation, and DNA repair. This finding raised an 
important question: how does modulation of HIF-1α regulate 
DNA repair? This could possibly be answered by consider-
ing the following points: first, UV irradiation can induce 
transcriptional expression of NER factors in cells;47,48 sec-
ond, UV irradiation modulates the expression of HIF-1α, 
a transcription factor;49 and third, software analysis has shown 
multiple potential hypoxia response elements (HRE) in the 
promoter regions of two important NER enzymes, XPC and 
XPD. Therefore, we tested the hypothesis that HIF-1α plays 
a critical role in the transcriptional regulation of XPC and 
XPD expression. The two NER enzymes (XPC and XPD) se-
lected for functional studies in human keratinocytes were 
found to be regulated by HIF-1α in a biphasic manner. Two 
HREs in the XPC promoter (hereafter named XPC-HRE1 and 
XPC-HRE2) were found to be critical for basal and UVB-
induced expression of XPC. A region of seven overlapping 
HREs in the XPD promoter has a crucial role in XPD ex-
pression. Our study demonstrated that the XPC-HRE2 region 
includes a HIF-1α-binding site and a Sp-1 binding site with 
overlapping bases. We found that binding of HIF-1α to 
XPC-HRE2 in non-irradiated cells inhibits the attachment of 
Sp-1 to the XPC promoter. The immediate down-regulation 
of HIF-1α after irradiation permits Sp-1 to bind to the XPC 
promoter, leading to the initial increase in XPC mRNA ex-
pression. Finally, there is late accumulation of phosphorylated 
HIF-1α protein following irradiation up-regulated XPC 
mRNA expression by direct binding to XPC-HRE1. Analysis 
of the repair kinetics of 6-4PPs and CPD revealed that 
HIF-1α down-regulation leads to an increased rate of im-
mediate removal of both photolesions but attenuates their 
late removal following UVB irradiation. Quantitative ChIP 
assays further revealed putative HREs in the genes encod-
ing other DNA repair proteins (XPB, XPG, chondroitin sul-
fate A and B48), suggesting that an additional role of HIF-1α 
in the epidermal system could be that of an important regu-
lator of the UV-dependent DNA repair machinery.50
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ROS, XPC, HIF-1 and the Warburg effect: 
deciphering the molecular aspects
Whatever causes underlie cancer (e.g. virus, mutation and 
DNA damage), tumor metabolism appears to be similar 
across a broad range of cancer types. Otto Warburg51 first 
showed the propensity for cancer cells to convert glucose to 
lactate even in the presence of oxygen, a phenomenon he 
had discovered in his work on tissue slices, at the beginning 
of the last century. He proposed that increased glycolysis is 
a paradigmatic feature of cancer cells. He showed that malig-
nant cells are more dependent on the glycolytic pathway 
for ATP generation compared with normal cells, even in the 
presence of sufficient oxygen concentration. He proposed 
that a respiratory deficiency might result in neoplastic trans-
formation,51 prompting many investigators to analyze the 
metabolism of tumor cells.52–54 These analyses revealed that 
cancer cells have a higher rate of glycolysis, an increased rate 
of glucose transport, increased pentose phosphate pathway 
activity, decreased numbers of mitochondria, and a reduction 
in mitochondrial oxidative phosphorylation proteins and 
activity compared with normal cells.52–54 The cause of the 
“Warburg Effect” has been much debated, and is still not well 
understood (reviewed by Stubbs and Griffiths55). However, 
the Warburg effect has been useful in clinical practice: posi-
tron emission tomography scans use the increased uptake of 
glucose as a diagnostic tool in oncology (Figure 5). Recent 
studies indicate that this metabolism variation in cancer cells 
could be related to somatic mutations in mitochondrial DNA, 
increased oxidative stress, and/or adaptation to environmen-
tal hypoxia.53,56,57 Investigation of pathways underlying the 
metabolic alteration has revealed that TP53, HIF-1α, c-MYC 
and PI3K could be involved in the balance between glycol-
ysis flux and mitochondrial respiration through regulation of 
different factors, and that changes in the expression of these 
factors could influence the metabolic shift.58–60
However, the causal relationship between genomic muta-
tions, the Warburg effect, and increased ROS levels in tumor 
induction remains unclear.53,56,61 Furthermore, there is no 
clear mechanism(s) linking genomic mutations and modified 
cellular bioenergetics. To understand the relationships be-
tween these factors, we speculated that cells with an in-
creased predisposition to becoming cancerous, or cells with 
the capacity to accumulate mutations, could be helpful in 
Figure 4 Hypoxia-inducible factors 1 (HIF-1), UV and DNA repair. Nucleotide excision repair genes have recently been discovered as HIF-1α 
target genes (see text for explanations).
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triggered by a standardizable environmental hazard (UV ir-
radiation). Based on the biochemical differences noted be-
tween two clinically distinct but molecularly related NER 
diseases, XP and TTD, we have been able to provide evi-
dence that antioxidant enzyme therapy is effective for pho-
toprotection, at least during the acute stage following UV 
irradiation. Further studies are necessary to determine if this 
therapy is effective following long term exposure to UV. We 
have shown the critical role of HIF-1 as a sensor not only of 
hypoxia but of other stresses in the epidermis, and as a major 
regulator of NER responses. Because the Warburg effect, 
a constant feature in cancer cells, can be detected down-
stream of XPC silencing, understanding the mechanisms lead-
ing to increased ROS in these cells is now a priority. This 
may ultimately lead to the implementation of new strategies 
for the prevention of skin as well as other cancers.
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